We have located links that may give you full text access.
Evaluation Studies
Journal Article
The use of multiple needle fasciotomy in Dupuytren disease: retrospective observational study of outcome and patient satisfaction.
Annals of Plastic Surgery 2014 April
PURPOSE: The aim of our study was to assess the efficacy, safety, and patient satisfaction of multiple needle fasciotomy for Dupuytren disease.
METHODS: During this observational study, patients who underwent the procedure between 2008 and 2010 were followed up, and outcomes, complications, and patient satisfaction were assessed.
RESULTS: Satisfaction rate was 75%, with no postoperative complications noted. As predicted, early recurrence rate was the main issue with a rate of 28% at the time of the questionnaire.
CONCLUSIONS: Percutaneous needle fasciotomy is a safe and efficient procedure in treating patients with early Dupuytren or those who would not potentially achieve good results with more aggressive surgical intervention.
METHODS: During this observational study, patients who underwent the procedure between 2008 and 2010 were followed up, and outcomes, complications, and patient satisfaction were assessed.
RESULTS: Satisfaction rate was 75%, with no postoperative complications noted. As predicted, early recurrence rate was the main issue with a rate of 28% at the time of the questionnaire.
CONCLUSIONS: Percutaneous needle fasciotomy is a safe and efficient procedure in treating patients with early Dupuytren or those who would not potentially achieve good results with more aggressive surgical intervention.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app